A Study of Lasmiditan in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 15, 2021

Primary Completion Date

July 6, 2021

Study Completion Date

July 6, 2021

Conditions

Healthy

Interventions

DRUG

Lasmiditan

Administered orally.

DRUG

Dabigatran Etexilate

Administered orally.

DRUG

Rosuvastatin

Administered orally.

Trial Locations (1)

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT04749914 - A Study of Lasmiditan in Healthy Volunteers | Biotech Hunter | Biotech Hunter